Growth-inhibition of cell lines derived from B cell lymphomas through antagonism of serotonin receptor signaling

A majority of lymphomas are derived from B cells and novel treatments are required to treat refractory disease. Neurotransmitters such as serotonin and dopamine influence activation of B cells and the effects of a selective serotonin 1A receptor (5HT1A) antagonist on growth of a number of B cell-der...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolan, Shrikant S., Lidström, Tommy, Mediavilla, Tomás, Dernstedt, Andy, Degerman, Sofie, Hultdin, Magnus, Björk, Karl, Marcellino, Daniel, Forsell, Mattias N. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414675/
https://www.ncbi.nlm.nih.gov/pubmed/30862884
http://dx.doi.org/10.1038/s41598-019-40825-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414675/
https://www.ncbi.nlm.nih.gov/pubmed/30862884
http://dx.doi.org/10.1038/s41598-019-40825-x

Ejemplares similares